YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(9)
- Austria(1)
- Belgium(4)
- Canada(60)
- China(26)
- Denmark(2)
- Estonia(2)
- Finland(1)
- France(13)
- Germany(44)
- Greece(2)
- Hong Kong(1)
- Hungary(2)
- India(79)
- Indonesia(1)
- Ireland(2)
- Israel(2)
- Italia (6)
- Japan(2)
- Latvia(1)
- Lithuania(1)
- Mexico(2)
- New Zealand(2)
- Peru(1)
- Poland(2)
- Portugal(3)
- Romania(1)
- Singapore(1)
- Slovenia(2)
- South Korea(6)
- Spain(17)
- Sweden(3)
- Switzerland(23)
- Taiwan(4)
- The Czech Republic(2)
- The Netherlands(6)
- Turkey(2)
- Ukraine(2)
- United Kingdom(57)
- United States(704)
- Vietnam(1)
Contract Service Directory
CNS Contract Research
Company Headquarters
550 University Ave
NRC Bldg. Suite 508
Charlottetown, PE C1A 4P3
Canada
Contract Service Directory
Related Content
-
Breaking News | Facilities | Industry News
Sai Life Sciences Opens New Biology Facility in Hyperbad, India
Positions itself as a differentiated player in Discovery Biology.08.19.21
-
Breaking News | Industry News | Promotions & Moves
Ashfield Health Appoints William Martino as Growth Director, North America
Martino has more than 20 years of leadership in healthcare marketing.08.19.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
AavantiBio, Aldevron Form Gene Therapy Partnership
Aldevron will supply plasmids to AavantiBio’s planned vector core and CDMO partners.07.27.21
-
Breaking News | Clinical Trials | Industry News | Information Technology
WCG Acquires eClinical Provider VeraSci
Aims to address growing demand for scientific and technology solutions for remote data capture, hybrid virtual studies and decentralized clinical trials.07.26.21
-
-
-
Breaking News | Industry News
Aptar Pharma, Nordic Semiconductor Partner on Digital Solutions
Nordic will supply its Bluetooth LE System-on-Chip used in Aptar’s range of digital healthcare solutions.Kristin Brooks 04.28.21
-
Breaking News | Collaborations & Alliances | Drug Development
Lilly, Rigel Enter Exclusive CNS Development Collaboration
Lilly will pay $125 million upfront and up to $835 million in potential milestones for Rigel's lead RIPK1 inhibitor, R552.Kristin Brooks 02.18.21
-
Biologics, Proteins, Vaccines | Clinical Trials
Inside a COVID Vaccine Trial
Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.Kristin Brooks, Managing Editor 02.05.21
-
Breaking News | Collaborations & Alliances | Drug Discovery
Metrion, LifeArc Extend Neuroscience Alliance
Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.Contract Pharma Staff 01.18.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Cyclolab and EpiPharma Form Joint Venture
Will develop and commercialize Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.Contract Pharma Staff 01.11.21
-
Breaking News | Collaborations & Alliances | Industry News
Angelini Pharma Acquires Arvelle Therapeutics for $960M
Angelini to become a leader in CNS and mental health disorder treatments; opening direct affiliates in France, UK, Nordics and Switzerland by 2022.Contract Pharma Staff 01.05.21
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
Passage Bio Invests in Gene Therapy Manufacturing R&D Site
In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.Contract Pharma Staff 12.17.20
-
Breaking News | cGMP Manufacture | Industry News
Passage Bio, Catalent Begin cGMP Mfg. for Gene Therapies
Completion of dedicated cGMP suite enhances manufacturing readiness and secures supply chain control to support lead CNS product candidates.Contract Pharma Staff 12.10.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
AC Immune and WuXi Biologics Expand Strategic Partnership
Plan to accelerate AC Immune’s TDP-43 antibody into clinical development.Contract Pharma Staff 11.10.20
-
Drug Delivery | Drug Development | Trials & Filings
Impel NeuroPharma Submits NDA for INP104 in Acute Migraine
Leverages the company’s Precision Olfactory Delivery technology11.09.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
Sai Life Sciences to Expand Biology Capabilities
Begins construction of new 75,000 sq. ft. facility in Hyderabad; adding 170 biologists to team.Contract Pharma Staff 10.28.20
-
Breaking News | Clinical Trials
CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin
Phase 2 trial will commence during the first quarter of 2021.Contract Pharma Staff 10.20.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Dyno, Roche Ink Gene Therapy Deal Worth up to $1.8B
Collaboration combines Dyno’s AI-powered AAV vector capabilities with Roche and Spark Therapeutics’ gene therapy capabilities.Contract Pharma Staff 10.14.20
-
APIs | Breaking News | Industry News
NCK A/S Receives CoA for Berubicin API
CNS has a contract with NCK A/S for the large-scale production of Berubicin, its lead drug candidate for the treatment of glioma brain tumors.Contract Pharma Staff 10.01.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
LSNE, Selecta Biosciences Form Mfg. Pact
LSNE to provide drug substance manufacturing and fill/finish services05.24.17
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Selexis SA and OSE Immunotherapeutics Enter Pact
Sign agreement for the development of OSE's interleukin receptor 7 antagonist05.24.17
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing | R&D
-
Clinical Trials | CRO News
PSI CRO to Open New Office in Durham
Aims to offer an ideal collaborative setting for both clients and staff in RTP05.10.16
-
Breaking News | Clinical Trials | Drug Development | Financial Reports
-
Breaking News | Drug Development | Formulation Development | Industry News | Methods Development
Sanofi Licenses Ligand’s Captisol Technology
Will use Captisol in the development and commercialization of cancer therapy SAR-12584407.30.15
-
Breaking News | Clinical Trials | Drug Development | Industry News | R&D
Novartis Acquires Spinifex Pharmaceuticals
Expands neuroscience portfolio with novel angiotensin II type 2 receptor antagonist for the treatment of chronic pain07.01.15
-
Breaking News | Financial Reports
